Here are four facts:
1. The credit rating indicates the company is a moderate default risk.
2. Morningstar also gave Zimmer Biomet stock a four-star rating.
3. Zimmer Biomet has a 50-day moving average of $100.96 and a 200-day moving average of $109.45.
4. The company has a market cap of $19.07 billion and a P/E ratio of 47.61.
More articles on devices:
Materialise, Lima partner on total knee replacements: 5 things to know
MedTorque releases new handle ratcheting for orthopedics, spine: 5 things to know
K2M commercially launches deformity spinal system in the US: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
